PT804229E - Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica - Google Patents
Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemicaInfo
- Publication number
- PT804229E PT804229E PT96901940T PT96901940T PT804229E PT 804229 E PT804229 E PT 804229E PT 96901940 T PT96901940 T PT 96901940T PT 96901940 T PT96901940 T PT 96901940T PT 804229 E PT804229 E PT 804229E
- Authority
- PT
- Portugal
- Prior art keywords
- amlodipine
- ace
- inhibitor
- defelodipine
- safety
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40510895A | 1995-03-16 | 1995-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT804229E true PT804229E (pt) | 2003-06-30 |
Family
ID=23602311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96901940T PT804229E (pt) | 1995-03-16 | 1996-02-26 | Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica |
Country Status (12)
Country | Link |
---|---|
US (1) | US6245787B1 (pt) |
EP (1) | EP0804229B1 (pt) |
JP (2) | JPH11500140A (pt) |
AT (1) | ATE235251T1 (pt) |
CA (1) | CA2215234C (pt) |
DE (1) | DE69626958T2 (pt) |
DK (1) | DK0804229T3 (pt) |
ES (1) | ES2193233T3 (pt) |
FI (1) | FI973691A0 (pt) |
MX (1) | MX9706957A (pt) |
PT (1) | PT804229E (pt) |
WO (1) | WO1996028185A2 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
EP0795327A1 (en) * | 1996-03-13 | 1997-09-17 | Pfizer Inc. | Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin |
FR2771010B1 (fr) * | 1997-11-19 | 2003-08-15 | Adir | Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires |
US6521647B2 (en) | 2000-04-04 | 2003-02-18 | Pfizer Inc. | Treatment of renal disorders |
GB0008332D0 (en) * | 2000-04-04 | 2000-05-24 | Pfizer Ltd | Treament |
EP1354602B1 (en) * | 2000-12-26 | 2006-10-04 | Sankyo Company, Limited | Medicinal compositions containing diuretic and insulin resistance-improving agent |
AR040017A1 (es) * | 2002-05-17 | 2005-03-09 | Novartis Ag | Combinacion de compuestos organicos |
US20040072879A1 (en) * | 2002-10-10 | 2004-04-15 | Dr. Reddy's Laboratories Limited | Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine) |
HUP0401170A2 (en) * | 2004-06-10 | 2006-09-28 | Richter Gedeon Vegyeszet | Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for |
US8158146B2 (en) | 2005-09-28 | 2012-04-17 | Teva Pharmaceutical Industries Ltd. | Stable combinations of amlodipine besylate and benazepril hydrochloride |
US20070142473A1 (en) * | 2005-12-15 | 2007-06-21 | Lawrence Solomon | Dosage forms and methods using ethacrynic acid |
EP2049089A4 (en) * | 2006-08-08 | 2012-07-04 | Accu Break Technologies Inc | PHARMACEUTICAL TABLET CONTAINING A PLURALITY OF ACTIVE SEGMENTS |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
PL2538924T3 (pl) | 2010-02-24 | 2014-10-31 | Sanofi Aventis Deutschland | Stałe formulacje farmaceutyczne ramiprylu i benzenosulfonianu amlodypiny oraz ich wytwarzanie |
RU2483728C1 (ru) * | 2011-09-29 | 2013-06-10 | Общество с ограниченной ответственностью "Озон" | Комбинированное гипотензивное средство и способ его получения |
WO2015153379A1 (en) * | 2014-04-01 | 2015-10-08 | Ailex Pharmaceuticals, Pvt. Ltd. | Fiixed dosage formulations of angiotensin converting enzyme (ace) inhibitor and the diuretic chlorthalidone |
US11452690B1 (en) | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
DE3633496A1 (de) | 1986-10-02 | 1988-04-14 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln |
US5155120A (en) | 1991-01-14 | 1992-10-13 | Pfizer Inc | Method for treating congestive heart failure |
NZ242724A (en) | 1991-05-15 | 1994-09-27 | Du Pont | Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker |
EP0795327A1 (en) | 1996-03-13 | 1997-09-17 | Pfizer Inc. | Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin |
-
1996
- 1996-02-26 WO PCT/IB1996/000145 patent/WO1996028185A2/en active IP Right Grant
- 1996-02-26 EP EP96901940A patent/EP0804229B1/en not_active Expired - Lifetime
- 1996-02-26 JP JP8527415A patent/JPH11500140A/ja not_active Withdrawn
- 1996-02-26 US US08/894,800 patent/US6245787B1/en not_active Expired - Fee Related
- 1996-02-26 PT PT96901940T patent/PT804229E/pt unknown
- 1996-02-26 CA CA002215234A patent/CA2215234C/en not_active Expired - Fee Related
- 1996-02-26 DE DE69626958T patent/DE69626958T2/de not_active Expired - Fee Related
- 1996-02-26 ES ES96901940T patent/ES2193233T3/es not_active Expired - Lifetime
- 1996-02-26 DK DK96901940T patent/DK0804229T3/da active
- 1996-02-26 MX MX9706957A patent/MX9706957A/es active IP Right Grant
- 1996-02-26 AT AT96901940T patent/ATE235251T1/de not_active IP Right Cessation
-
1997
- 1997-09-15 FI FI973691A patent/FI973691A0/fi not_active Application Discontinuation
-
2003
- 2003-04-16 JP JP2003111582A patent/JP2003286170A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2215234C (en) | 2001-12-11 |
WO1996028185A3 (en) | 1996-10-17 |
JPH11500140A (ja) | 1999-01-06 |
ATE235251T1 (de) | 2003-04-15 |
MX9706957A (es) | 1997-11-29 |
DK0804229T3 (da) | 2003-04-22 |
US6245787B1 (en) | 2001-06-12 |
FI973691A (fi) | 1997-09-15 |
JP2003286170A (ja) | 2003-10-07 |
DE69626958T2 (de) | 2004-03-18 |
FI973691A0 (fi) | 1997-09-15 |
ES2193233T3 (es) | 2003-11-01 |
CA2215234A1 (en) | 1996-09-19 |
DE69626958D1 (de) | 2003-04-30 |
WO1996028185A2 (en) | 1996-09-19 |
EP0804229A2 (en) | 1997-11-05 |
EP0804229B1 (en) | 2003-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT804229E (pt) | Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica | |
BR9714363A (pt) | Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas | |
BR9812030A (pt) | Combinações terapêuticas compreendendo amlodipina e atorvastatina | |
CO4970726A1 (es) | Terapia de combinacion pino y atorvastatina utiles en el tratamiento de angina de pecho, ateroesclerosis,hipertension e hiperlipidemia | |
DK0479903T3 (da) | Substituerede imidazoler og deres anvendelse som angiotensin II hæmmere | |
MY121008A (en) | Combination therapy comprising atorvastatin and an antihypertensive agent. | |
DK0891331T3 (da) | N-(2-Oxoacetyl- eller sulfonyl)pyrrolidin/piperidin-2-carboxylsyrederivater med forbedret multi-lægemiddelresistensaktivitet | |
AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
BR9803168A (pt) | Tratamento de parada cardìaca congestiva. | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
NO20000446D0 (no) | Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser | |
DK0680323T3 (da) | Synergistisk kombination med antagonistvirkning ved NK1- og Nk2-receptorer. | |
ATE275966T1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
DK0859613T3 (da) | Anvendelse af flupirtin til forebyggelse og behandling af sygdomme, som er forbundet med beskadigelse af det hæmopoietiske cellesystem | |
DE69621786T2 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
WO1998022099A3 (en) | New use of creatine | |
AU4937499A (en) | Use of succinic acid or salts thereof and method of treating insulin resistance | |
SE9602262D0 (sv) | New use of derivatives of cystine | |
NO960347L (no) | Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF | |
EP0880967A3 (de) | Nephroprotektive Arzneimittel | |
NO961046D0 (no) | Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre | |
FI20010233A0 (fi) | Menetelmä sydämen vajaatoiminnan hoitoon | |
ES2174272T3 (es) | Utilizacion del (r)-verapamilo como medicamento para el tratamiento de la angina. | |
DE59505934D1 (de) | Vitamin b 12-haltige sanddornkonzentrate oder -extrakte |